Evidence map›Paper›PMID 14755246›Full record

ArticleOncogene2004

Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome.

Ashani T Weeraratna, Dorothea Becker, Kristen M Carr, Paul H Duray, Kevin P Rosenblatt, Sherry Yang, Yidong Chen, Michael Bittner, Robert L Strausberg, Gregory J Riggins and 5 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00340522 (Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development), which is not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00340522 completednot on this map

Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development

TypeobservationalSponsorNational Cancer Institute (NCI)Ran2004 to 2014Enrolled20ConditionsCancer
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Article
  3. Claudin-1, A Double-Edged Sword in Cancer.International journal of molecular sciences · 2020
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Wnt5A activates the calpain-mediated cleavage of filamin A.The Journal of investigative dermatology · 2009
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 3 countries.

Ashani T WeeraratnaLaboratory of Immunology, National Institutes of Health, The National Institute on Aging, Baltimore, MD 21224, USA. weerarat@grc.nia.nih.gov
Dorothea Becker
Kristen M Carr
Paul H Duray
Kevin P Rosenblatt
Sherry Yang
Yidong Chen
Michael Bittner
Robert L Strausberg
Gregory J Riggins
Urs Wagner
Olli P Kallioniemi
Jeffrey M Trent
Patrice J Morin
Paul S Meltzer
National Institutes of Health · USNational Cancer Institute · USNational Human Genome Research Institute · USTranslational Genomics Research Institute · USTurku Centre for Biotechnology · FIJ. Craig Venter Institute · USJohns Hopkins University · USUniversity of Basel · CHUniversity of Pittsburgh · US

Funding

MOLECULAR STUDIES OF OVARIAN CANCER AND THE WNT PATHWAY IN HUMAN CANCERZ01AG000512 · NIA · AGING · PI MORIN, PATRICE J. · 1998 to 2007
$1.5M
Using gene expression profiles to elucidate mechanisms of melanoma progressionZ01AG000442 · NIA · NATIONAL INSTITUTE ON AGING · PI WEERARATNA, ASHANI · 2004 to 2008
$1.3M
Using gene expression profiles to elucidate mechanisms of melanoma progressionZIAAG000442 · NIA · NATIONAL INSTITUTE ON AGING · PI WEERARATNA, ASHANI · 2009 to 2010
$443k
Functional genomics of cancerZ01HG000186 · NHGRI · HUMAN GENOME RESEARCH · PI MELTZER, PAUL S. · 2001 to 2005
–
6 · The paper itself

Abstract

In this study, we generated three SAGE libraries from melanoma tissues. Using bioinformatics tools usually applied to microarray data, we identified several genes, including novel transcripts, which are preferentially expressed in melanoma. SAGE results converged with previous microarray analysis on the importance of intracellular calcium and G-protein signaling, and the Wnt/Frizzled family. We also examined the expression of CD74, which was specifically, albeit not abundantly, expressed in the melanoma libraries using a melanoma progression tissue microarray, and demonstrate that this protein is expressed by melanoma cells but not by benign melanocytes. Many genes involved in intracellular calcium and G-protein signaling were highly expressed in melanoma, results we had observed earlier from microarray studies (Bittner et al., 2000). One of the genes most highly expressed in our melanoma SAGE libraries was a calcium-regulated gene, calpain 3 (p94). Immunohistochemical analysis demonstrated that calpain 3 moves from the nuclei of non-neoplastic cells to the cytoplasm of malignant cells, suggesting activation of this intracellular proteinase. Our SAGE results and the clinical validation data demonstrate how SAGE profiles can highlight specific links between signaling pathways as well as associations with tumor progression. This may provide insights into new genes that may be useful for the diagnosis and therapy of melanoma.

Indexed as

Gene LibraryMuscle ProteinsAgedAged, 80 and overAntigens, Differentiation, B-LymphocyteCalpainCell Line, TumorComputational BiologyExpressed Sequence TagsFemaleHistocompatibility Antigens Class IIHumansImmunohistochemistryIsoenzymesMaleMelanomaAntigens, Differentiation, B-LymphocyteCalpainCAPN3 protein, humanHistocompatibility Antigens Class IIinvariant chainIsoenzymesMuscle Proteins

Identifiers

PMID14755246
OpenAlexW1974657780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.